Navigation Links
Collaborative Drug Discovery 2nd Annual Community Meeting - Oct. 7, 2008, Speakers Confirmed & Call for Posters
Date:7/31/2008

BURLINGAME, Calif., July 31 /PRNewswire/ -- Collaborative Drug Discovery invites you to submit your poster presentation and register at http://www.acteva.com/go/cdd to attend the 2nd Annual CDD Community Meeting (a free, 1-day event) on October 7th. The CDD Community Meeting is the best place for the CDD community and all scientists to get together, discuss their research projects, and showcase their work to others in the community.

Early List of Confirmed Speakers:

-- David Sullivan, MD, Johns Hopkins

-- Fred Buckner MD, University of Washington

-- Janice Kranz, PhD, Stanley Center for Psychiatric Research, Broad

Institute of MIT & Harvard

-- Conor Caffrey, PhD, Sandler Center, UCSF

-- Jean Claude-Bradley, PhD Dept. of Chemistry, Drexel University

-- Sean Ekins, PhD, ex-Pfizer/Lilly Computational Chemist

-- Andrea Altieri, PhD, ASINEX

-- Robert Damoiseaux, PhD, UCLA Molecular Screening Shared Resource (MSSR)

Center

-- Moses Hohman, PhD, Head of Software, Collaborative Drug Discovery (CDD

roadmap)

-- J. Leighton Read, MD (Alloy Ventures) -- Financing Biomedical

Innovation from academia to the market: From FluMist(TM) to Priority

Review Vouchers and other stories

-- Russell "Rusty" Bromley, Chief Operating Officer, Myelin Repair

Foundation

Timely panel topics:

-- Panel #1: What Foundations are looking for from Academic researchers?

-- Panel #2: What makes collaborations successful within and between

groups?

Who should attend?

-- Scientists working in drug discovery

-- Researchers who are involved in collaborations or generate complex drug

discovery data

-- Students who want to learn more about the drug discovery industry

-- People who wish to network, establish new or strengthen existing

collaborations

-- Current CDD community members to set the collaborative platform's

future direction

-- Anyone interested in new drugs for diseases of the developing world,

private public partnerships, and/or global health

So register now at http://www.acteva.com/go/cdd to join us on October 7th at the J. David Gladstone Research Institute (UCSF Mission Bay Campus, 1650 Owens Street, San Francisco, CA).

About Collaborative Drug Discovery, Inc.

Collaborative Drug Discovery, Inc. (CDD) -- http://www.collaborativedrug.com -- provides web-based software that organizes preclinical research data to help scientists advance new drug candidates more effectively. The CDD database enables scientists to "archive, mine, and collaborate"(R) around preclinical chemical and biological drug discovery data through a web-based interface. The software helps distributed research groups to safely store and intelligently analyze small molecule, enzyme, cell and animal bioactivity data accumulated from both low-throughput and high-throughput screens. Unique collaboration features and CDD's community-oriented approach help unite globally dispersed humanitarian efforts against neglected infectious diseases. Similar collaborative strategies are also rapidly gaining prominence in the commercial arena. CDD offers its industrial-strength database software at a price affordable to academic laboratories, research foundations, and small companies.


'/>"/>
SOURCE Collaborative Drug Discovery, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
2. Medpedia Announced, Worlds Largest Collaborative Online Encyclopedia of Medicine and Health
3. Access Granted to Present at the Collaborative Communications Summit: Health Technology Investment Forum
4. Patient Centered Primary Care Collaborative Statement on Passage of Medicare Bill
5. Collaborative Launches Initiative to Protect Rights of Parents with Mental Illnesses
6. American Red Cross and NSF Scrub Club(R) Announce Collaborative Agreement
7. DFG establishes 8 new Collaborative Research Centers
8. Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership
9. Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech
10. The Leukemia & Lymphoma Society and MannKind Corporation Announce Collaborative Research Agreement
11. Rural Maryland Hospitals Form Unprecedented Collaborative to Improve Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... ... On Dec. 2, 2016, CURE® magazine will host the 4th Annual MPN ... Heroes—eight individuals who have made a difference in the field of rare blood cancers ... demonstrating leadership within the MPN community and/or a commitment to individual patients. , This ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... the Dothan-Wiregrass Area in Alabama are expected to attend the UNCF Dothan-Wiregrass Mayor’s ... help provide scholarship funds for area students and operating support to UNCF-member institutions, ...
(Date:12/2/2016)... California (PRWEB) , ... December 02, 2016 , ... ... professionals, proudly announces the launch of its 60-day free trial program for all ... trip shipping make the offer a truly hassle free experience. , FlexiSpot’s unique ...
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame to change Medicare ... Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from ... (Part D) need to make changes during this period order for their new policy ...
(Date:12/2/2016)... ... 02, 2016 , ... With the number of pain management programs available for ... find the one that works for them. When an inventor from Suisun City, Calif., ... and decided to share it with others. , He developed a prototype for PRO ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Research and Markets has announced the addition of Jain ... and Companies" to their offering. ... , , Drug ... market value of drug delivery technologies and the anticancer drugs are ... to organs involved and the types of cancer as well as ...
(Date:12/2/2016)... -- Around the corners of world, cancer has infused ... present over earth. Cancer has become one of those ... time this is because of the increasing incidence rates ... steady increase in global cancer incidence with its associated ... of treatment, there is increasing interest in this stringent ...
(Date:12/2/2016)... -- Allergan plc (NYSE: AGN ), a leading ... announced Accelerated Share Repurchase (ASR) Program. Logo - ... , ... announced, the Company entered into a variable tenor ASR arrangement ... $10 billion of its ordinary shares. Approximately 40.5 million shares ...
Breaking Medicine Technology: